Posts Tagged ‘O₂’
New Expert Guidelines from IWGDF Highlight the Growing International Recognition of Topical Oxygen Therapy (TOT) for Diabetic Foot Ulcers
The International Working Group on the Diabetic Foot (IWGDF) have recently released updated guidelines recommending the use of topical oxygen therapy (TOT) for wound healing. The updated guidelines endorse TOT as an adjunct therapy in the treatment of diabetic foot ulcers (DFUs). With its endorsement by leading experts in the field, this ground-breaking therapy is poised to transform the lives of millions of people worldwide, offering renewed hope for effective healing and improved quality of life.
This comprehensive set of recommended DFU interventions, developed by a panel of renowned experts in the field whose mission is to prevent and manage diabetic foot disease, serves as a trusted resource for healthcare professionals worldwide. With its inclusion in the IWGDF guidelines, topical oxygen therapy emerges as a vital tool, poised to revolutionize the management and healing of foot ulcers in individuals with diabetes.
Read MoreRaise Healthcare Named UK Distributor for NATROX® Wound Care
We’re excited to announce Raise Healthcare as our exclusive distributor in the United Kingdom. Raise Healthcare is a UK-based specialist medical device distributor known for its extensive portfolio of life-changing products.
“This partnership brings together Raise Healthcare’s experienced team with NATROX®’s innovative wound care therapy,” said Rajesh Nair, Director for Raise Healthcare. “We invest time and resources to understand the needs of patients so we can provide exceptional products such as NATROX® O₂ that positively impact lives every day.”
Read MoreNATROX® Symposium at EWMA 2023
Join us 3 May at EWMA for a ground breaking symposium. Learn how innovative topical oxygen therapy helps deliver substantial, rapid pain relief and can support an end to opioid use completely. This new therapy is a novel alternative to hyperbaric oxygen therapy (HBOT) in the treatment of chronic wounds, providing an easily accessible, low-cost option for improved wound healing.
Featured speakers include Dr. Thomas Serena from the SerenaGroup and Dr. Jakob WIkström from the Karolinska University Hospital in Sweden.
Read MoreHealth Technology Wales Guidance Advises Routine Adoption of NATROX® O₂
Health Technology Wales (HTW) has published Guidance advising the routine adoption of NATROX® O₂ for the treatment of chronic, non-healing and complex diabetic foot ulcers (DFUs).
“We have the opportunity right now to reshape the future. We’ve all seen the statistics on diabetes—and frankly, they’re depressing. What motivates our team is seeing the positive impact NATROX® O₂ makes on patients every day. Being included in this Guidance is another step towards shaping a future we can all feel inspired by,” said Kennedy.
Read MoreNew Expert Opinion in Support of Topical Oxygen Therapy (TOT)
Experts agree that “topical oxygen therapy has come of age and the evidence supporting its efficacy in healing chronic diabetic foot ulcers can no longer be disputed.”
Read MoreDelphi Consensus on Guidelines for the Use of Topical Oxygen
Delphi participants reached a consensus on when to prescribe topical oxygen therapy (TOT). Experts recommend using TOT in diabetic foot ulcers (DFUs) and supported payer reimbursement for this therapy modality. Experts agreed TOT should be considered in the following circumstances: Wound types likely to benefit: DOWNLOAD NOW
Read MoreHow wound care clinicians can optimize clinical outcomes and resources
Dr. Aliza Lee, DPM, MS, ABPM, Director of Podiatric Medical Education, Staff Podiatrist, and Clinical Research Investigator (at the V.A. Hospital in Salem, Virginia presents her latest 12-week study on 8 patients exploring the combined use of NATROX® O₂ with an advanced digital platform using Telehealth to understand the clinical benefits.
Read MoreNew poster presented at DFCon 2022 by Dr. Lee
Managing patients with chronic non-healing wounds is challenging particularly for those in rural communities. This small, pilot study over 12-week study aimed to explore whether NATROX® Oxygen Wound Therapy (cTOT) in conjunction with an advanced digital platform with telehealth capabilities can offer clinical benefits while optimizing the limited clinical resources. During the study, patient-clinician interactions…
Read MoreNATROX® O₂ Masterclass Guide
A new guide has been published in Wound Masterclass. It provides an overview on NATROX® O₂ and how it works. It covers what wounds are suitable and what wounds are not. It shows the stages of treatment, and also covers the clinical evidence and efficacy, including data on wound size reduction.
Read MoreNATROX® Wound Care Ranks Number One for its Innovative Medical Technology
We are pleased to announce we have ranked number one in the MedTech50, recognised as the UK’s most innovative medical technology creator for 2022. The Business Cloud award honours companies helping diagnose and treat conditions mainly in a clinical setting. It spotlights the top 50 UK firms blazing a trail by creating original technology for the healthcare and medical sectors.
For the third consecutive year, the company has ranked in the top 50. However, this year, it catapulted its way to first place. The final MedTech50 ranking was decided by a combination of an independent judging panel and a public vote on the shortlist of companies which attracted around 800 votes.
Read More